Home / Brands / Pfizer Us Pharmaceutical Group
Pfizer Us Pharmaceutical Group Recalls
4 recalls on record · November 27, 2013 to July 2, 2014 · Drugs
Recalls by year
13
14
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
July 2, 2014DrugsFDA
Pfizer Us Pharmaceutical Group recalls Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg, 30 count bottle, Rx only, Distributed by Wyeth Pharmaceuticals,
Hazard: Presence of Foreign Tablets/Capsules: Pfizer is recalling 50 mg Pristiq (desvenlafaxine) extended release tablets because a single Pristiq 100 mg tablet was found in a bottle of 50 mg Pristiq.
May 28, 2014DrugsFDA
Pfizer Us Pharmaceutical Group recalls Effexor XR (venlafaxine HCl) Extended-Release Capsules, 150 mg, packaged in a) 30-count Unit of Use bottles (NDC 0008-08
Hazard: Presence of Foreign Tablets/Capsules: A Pharmacist reported that a bottle of Effexor XR 150 mg capsules contained a single peach colored capsule printed TKN250 which was identified as a Tikosyn (dofetilide) capsule.
March 26, 2014DrugsFDA
Pfizer Us Pharmaceutical Group recalls Advil PM Caplets, (Ibuprofen, 200 mg /Diphenhydramine citrate, 38 mg) 120 count bottle, OTC, Pfizer, Madison, NJ 07940 U
Hazard: Subpotent Drug: This lot is being recalled because of out-of-specification test results for Diphenhydramine citrate.
November 27, 2013DrugsFDA
Pfizer Us Pharmaceutical Group recalls Aldactone (spironolactone) tablets, USP, 100 mg, 100-count bottles, Rx only, Distributed by G.D. Searle, Division of Pfi
Hazard: Marketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing site change. There is currently no approved application supporting the alternate manufacturing site.